Store Price

Nobivac Canine 1-DAPPv a vaccine recommended for use in healthy dogs as an aid in the prevention of disease caused by canine distemper virus, adenovirus type 1 (hepatitis) and adenovirus type 2 (respiratory disease), canine parainfluenza virus, and canine parvovirus. Canine Distemper, Adenovirus Type 2, Parainfluenza, Parvovirus Vaccine, MODIFIED LIVE VIRUS Proven 1-year vacine that offers broad protection against ccanine parvovirus (CPV), adenovirus type 1 (hepatitis) and type 2 (respiratory disease), parainfluenza, and distemper. Protects against all known strains of CPV, including CPV-2c.1-2 High antigenic mass (titer), low passage parvovirus vaccine Canine vaccine containing CPV-2b, one of the most prevalent field strains of parvovirus Protects against 2 types of adenovirus that cause hepatitis and respiratory disease in dogs Provides disease coverage for commonly spread canine viruses, distemper, adenovirus types 1 and 2, parainfluenza and parvovirus in 1 formula First to publish data showing protection against CPV-2c challenge.1 Multiple studies demonstrate the ability to override maternal antibodies.3 Indications Approved for the vaccination of healthy dogs as an aid in the precention of disease caused by canine distemper virus, adenovirus types 1 and 2, parainfluenza, and parvovirus Recommended for use in healthy dogs 6 weeks of age or older Nobivac is a registered trademark of Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co. Inc.

Sku N010626


No reviews

Write a review

Your review will appear on the website after it has been approved. Thank you for your contribution.

Sign up to our Newsletter

Sign up content.